Clinical trial
A Multicenter, Open Label Phase-1/2a Study of Oftac Eye Drops in Active Non-Infectious Anterior Uveitis Patients
NCT07869953 is registered in ClinicalTrials.gov with BioNanoSim Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open Label Phase-1/2a Study of Oftac Eye Drops in Active Non-Infectious Anterior Uveitis Patients
- Lead sponsor
- BioNanoSim Ltd.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 7, 2024
- Completion date
- March 25, 2025
- Enrollment
- 18 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
non-infectious anterior uveitis